Public Policy & NGOs
Here's a look at documents from public policy and non-governmental organizations
Public Policy & NGOs
Featured Stories
World Vision International: Study Highlights the Importance of Supporting Maternal, Infant and Young Child Practices in Conflict-affected Border of Cambodia
MONROVIA, California, Nov. 21 -- World Vision International issued the following news release:
* * *
New Study Highlights the importance of supporting Maternal, Infant and Young Child Practices in conflict-affected Border of Cambodia
New Study Highlights the importance of supporting Maternal, Infant and Young Child Practices in conflict-affected Border of Cambodia
-
Phnom Penh, 19 November 2026 - A new qualitative study by World Vision International in Cambodia (WVI-C) and Cambodia Development Resource Institute (CDRI) explores how the the Cambodia-Thailand border conflict affected household ... Show Full Article MONROVIA, California, Nov. 21 -- World Vision International issued the following news release: * * * New Study Highlights the importance of supporting Maternal, Infant and Young Child Practices in conflict-affected Border of Cambodia New Study Highlights the importance of supporting Maternal, Infant and Young Child Practices in conflict-affected Border of Cambodia - Phnom Penh, 19 November 2026 - A new qualitative study by World Vision International in Cambodia (WVI-C) and Cambodia Development Resource Institute (CDRI) explores how the the Cambodia-Thailand border conflict affected householdfood security, livelihoods, access to nutrition services, and caregiving practices in conflict-affected communities. The finding highlights the importance of continued support of pregnant women, breastfeeding mothers, infants, and young children during emergencies.
Conducted in WVI's AP sites of Battambang, Banteay Meanchey, and Siem Reap provinces, the study explored how displacement, income losses, food and market disruptions, and living environment influenced Maternal, Infant and Young Child Feeding (MIYCF) practices, particularly among those who experienced displaced, impactful, and returned migrant households. Families described struggling to access diverse and nutritious foods due to declining incomes, rising food prices, change in market availability, security concerns, and restricted movement. As a result, some households adapted by relying on affordable and ready available foods, which made it more difficult to maintain dietary diversity and access to nutrient-rich foods such as meat, fruits, and vegetables for food consumption in the households.
The study also explored the experiences of mothers in maintaining breastfeeding during the conflict. Some mothers reported concerns about their breast milk supply, which they associated with changes in their food intake, limited dietary diversity, and psychological stress during displacement. These concerns influenced some mothers' feeding decisions, including stopping breastfeeding earlier than intended or introducing other milk products or complementary foods before infants reached six months of age. Families who already use breast milk substitutes faced double constraints, and also described challenges in obtain these products due to increased prices, limited availability, and difficulties travelling to purchase them during the conflict. These experiences highlight the importance of accessible breastfeeding counselling, practical assistance, and psychosocial support to help mothers address feeding concerns and maintain recommended practices.
In response to these challenges, families described a range of coping strategies, including rationing food, borrowing money, using savings, selling productive assets, fishing, and relying more heavily on locally available foods. Some of these strategies, including borrowing, drawing on savings, and selling productive assets, carry longer-term costs for household income and food security. Support from local authorities, health workers, community volunteers, monks, and humanitarian organizations also helped affected households meet immediate needs. However, the study highlighted opportunities to further strengthen emergency assistance by incorporating greater attention to dietary diversity and the specific nutritional needs of pregnant women, breastfeeding mothers, infants, and young children.
The study further highlighted the importance of accessible and continuous maternal and child health and nutrition support during emergencies. Participants described varying experiences in accessing routine and essential services such as growth monitoring, breastfeeding counselling, complementary feeding and community-based support. Pregnant women, children under two years of age, and displaced households were among the most affected groups. Health workers, community volunteers, local authorities, and humanitarian organisations played important roles in supporting affected families. The findings point to opportunities to further strengthen coordination and continuity of essential support, particularly for pregnant and lactating women, infants, young children, and displaced households.
The study recommends strengthening MIYCF in emergency preparedness and response through continued access to essential maternal and child nutrition services, strengthening breastfeeding and complementary feeding support, ensuring access to diverse and nutritious foods, and stronger community-based support and referral systems, and appropriate facilities for mothers and young children in displacement settings. Timely and flexible resources, together with coordination among government institutions, local authorities, development partners, and humanitarian organisations, are important to ensure that support responds to families' needs throughout emergency response, return, and recovery.
"The evidence generated through this study will help inform our collective efforts to strengthen emergency preparedness and responses for mothers and young children. By better understanding the experiences and challenges faced by families during the conflict, we can work together with government institutions and partners to design and implement more effective and responsive programmes that protect nutrition and build resilience," said Dr. Than Thi Ha, Acting National Director of World Vision International in Cambodia.
* * *
About CDRI: CDRI works to produce independent, objective, high quality policy-relevant development research, to maximise its accessibility to policy makers, influencers and stakeholders and to have it affect policy in five interrelated areas that are key for Cambodia's sustainable development: Policy Research in Agriculture and Rural Development; Development Economics and Trade; Educational Research and Innovation; Natural Resource and Environment; and Governance and Inclusive Society.
* * *
About World Vision Cambodia: World Vision International in Cambodia is a Christian humanitarian and development organization dedicated to working with children, their families, and communities to overcome poverty and injustice. World Vision serves the world's most vulnerable people, regardless of religion, race, ethnicity, or gender. In times of crisis, World Vision maintains a non-political and impartial humanitarian approach, with the primary aim of protecting and supporting vulnerable children and families affected by emergencies, regardless of their background or ethnicity.
* * *
Original text here: https://www.wvi.org/newsroom/cambodia/joint-press-release-new-study-highlights-importance-supporting-maternal-infant
[Category: Sociological]
* * *
New Study Highlights the importance of supporting Maternal, Infant and Young Child Practices in conflict-affected Border of Cambodia
New Study Highlights the importance of supporting Maternal, Infant and Young Child Practices in conflict-affected Border of Cambodia
-
Phnom Penh, 19 November 2026 - A new qualitative study by World Vision International in Cambodia (WVI-C) and Cambodia Development Resource Institute (CDRI) explores how the the Cambodia-Thailand border conflict affected household ... Show Full Article MONROVIA, California, Nov. 21 -- World Vision International issued the following news release: * * * New Study Highlights the importance of supporting Maternal, Infant and Young Child Practices in conflict-affected Border of Cambodia New Study Highlights the importance of supporting Maternal, Infant and Young Child Practices in conflict-affected Border of Cambodia - Phnom Penh, 19 November 2026 - A new qualitative study by World Vision International in Cambodia (WVI-C) and Cambodia Development Resource Institute (CDRI) explores how the the Cambodia-Thailand border conflict affected householdfood security, livelihoods, access to nutrition services, and caregiving practices in conflict-affected communities. The finding highlights the importance of continued support of pregnant women, breastfeeding mothers, infants, and young children during emergencies.
Conducted in WVI's AP sites of Battambang, Banteay Meanchey, and Siem Reap provinces, the study explored how displacement, income losses, food and market disruptions, and living environment influenced Maternal, Infant and Young Child Feeding (MIYCF) practices, particularly among those who experienced displaced, impactful, and returned migrant households. Families described struggling to access diverse and nutritious foods due to declining incomes, rising food prices, change in market availability, security concerns, and restricted movement. As a result, some households adapted by relying on affordable and ready available foods, which made it more difficult to maintain dietary diversity and access to nutrient-rich foods such as meat, fruits, and vegetables for food consumption in the households.
The study also explored the experiences of mothers in maintaining breastfeeding during the conflict. Some mothers reported concerns about their breast milk supply, which they associated with changes in their food intake, limited dietary diversity, and psychological stress during displacement. These concerns influenced some mothers' feeding decisions, including stopping breastfeeding earlier than intended or introducing other milk products or complementary foods before infants reached six months of age. Families who already use breast milk substitutes faced double constraints, and also described challenges in obtain these products due to increased prices, limited availability, and difficulties travelling to purchase them during the conflict. These experiences highlight the importance of accessible breastfeeding counselling, practical assistance, and psychosocial support to help mothers address feeding concerns and maintain recommended practices.
In response to these challenges, families described a range of coping strategies, including rationing food, borrowing money, using savings, selling productive assets, fishing, and relying more heavily on locally available foods. Some of these strategies, including borrowing, drawing on savings, and selling productive assets, carry longer-term costs for household income and food security. Support from local authorities, health workers, community volunteers, monks, and humanitarian organizations also helped affected households meet immediate needs. However, the study highlighted opportunities to further strengthen emergency assistance by incorporating greater attention to dietary diversity and the specific nutritional needs of pregnant women, breastfeeding mothers, infants, and young children.
The study further highlighted the importance of accessible and continuous maternal and child health and nutrition support during emergencies. Participants described varying experiences in accessing routine and essential services such as growth monitoring, breastfeeding counselling, complementary feeding and community-based support. Pregnant women, children under two years of age, and displaced households were among the most affected groups. Health workers, community volunteers, local authorities, and humanitarian organisations played important roles in supporting affected families. The findings point to opportunities to further strengthen coordination and continuity of essential support, particularly for pregnant and lactating women, infants, young children, and displaced households.
The study recommends strengthening MIYCF in emergency preparedness and response through continued access to essential maternal and child nutrition services, strengthening breastfeeding and complementary feeding support, ensuring access to diverse and nutritious foods, and stronger community-based support and referral systems, and appropriate facilities for mothers and young children in displacement settings. Timely and flexible resources, together with coordination among government institutions, local authorities, development partners, and humanitarian organisations, are important to ensure that support responds to families' needs throughout emergency response, return, and recovery.
"The evidence generated through this study will help inform our collective efforts to strengthen emergency preparedness and responses for mothers and young children. By better understanding the experiences and challenges faced by families during the conflict, we can work together with government institutions and partners to design and implement more effective and responsive programmes that protect nutrition and build resilience," said Dr. Than Thi Ha, Acting National Director of World Vision International in Cambodia.
* * *
About CDRI: CDRI works to produce independent, objective, high quality policy-relevant development research, to maximise its accessibility to policy makers, influencers and stakeholders and to have it affect policy in five interrelated areas that are key for Cambodia's sustainable development: Policy Research in Agriculture and Rural Development; Development Economics and Trade; Educational Research and Innovation; Natural Resource and Environment; and Governance and Inclusive Society.
* * *
About World Vision Cambodia: World Vision International in Cambodia is a Christian humanitarian and development organization dedicated to working with children, their families, and communities to overcome poverty and injustice. World Vision serves the world's most vulnerable people, regardless of religion, race, ethnicity, or gender. In times of crisis, World Vision maintains a non-political and impartial humanitarian approach, with the primary aim of protecting and supporting vulnerable children and families affected by emergencies, regardless of their background or ethnicity.
* * *
Original text here: https://www.wvi.org/newsroom/cambodia/joint-press-release-new-study-highlights-importance-supporting-maternal-infant
[Category: Sociological]
Groundwork Center for Resilient Communities: What's Possible in the Wake of MOP UP Ballot Passing?
TRAVERSE CITY, Michigan, Nov. 21 -- Groundwork Center for Resilient Communities issued the following news:
* * *
What's possible in the wake of MOP UP ballot passing?
November 20, 2026
AUTHOR: Nicholas Jansen
In the midst of a midterm election that set all-time highs for spending by corporations and dark money political action committees, Michigan took its first step toward getting money out of politics. Proposal 2, approved on November 3 by 80% of voters, restricts campaign donations from utilities and government contractors that have contracts with the state worth over $250,000. While this ... Show Full Article TRAVERSE CITY, Michigan, Nov. 21 -- Groundwork Center for Resilient Communities issued the following news: * * * What's possible in the wake of MOP UP ballot passing? November 20, 2026 AUTHOR: Nicholas Jansen In the midst of a midterm election that set all-time highs for spending by corporations and dark money political action committees, Michigan took its first step toward getting money out of politics. Proposal 2, approved on November 3 by 80% of voters, restricts campaign donations from utilities and government contractors that have contracts with the state worth over $250,000. While thisis a relatively narrow scope, Prop 2 is a meaningful step toward rebuilding trust between Michiganders and their leaders.
And in Michigan, rebuilding trust is crucial, as our state government ranks 48th nationally in government transparency--in part because of the influence money has in our elections and lobbying efforts. Take for example the 2026 midterm election campaigns, in which about $767 million was spent on political advertising, ranking the state fourth-highest nationally. Corporations, wealthy individuals, and dark money groups understand their buying power. Time and time again they've put it to use trying to sway our elections and then tilt legislative policies their way. For instance, DTE and Consumers Energy spent a combined $215,000 to stop Proposal 2, and meanwhile they have donated to 92% of the current state legislative members. That kind of influence is not working for everyday Michiganders, who pay some of the highest electric rates in the nation while experiencing some of the most frequent and prolonged power outages.
Removing corporate influence is crucial, as Christy McGillivray from Voters Not Politicians, which sponsored the Proposal 2 ballot initiative, shared, "This is a long-game of building a shared sense of reality by uniting over a shared commitment of fighting corruption." When looking at the concerns over data centers, bitcoin mines, and flock cameras, we know Big Tech is also pumping money into our state legislature. This is a great first step at restoring power to the people, but we are not done!
Regarding dirty and unreliable energy in Michigan, what can we do now that Prop 2 has passed, and utility influence-spending is cut off? There have been a number of bills introduced in Michigan's legislature the past few years that were designed to combat rising prices and grid instability, but they failed, in large part, due to utility opposition and influence. We now have a favorable landscape where we can pass laws to promote proven technologies, such as virtual power plants, community solar, and plug-in solar, to help lower electricity cost while also strengthening our grid.
Proposal 2 opens the door for much good change. But, not surprisingly, the utilities and others who must curtail their political spending are pushing back. Thus far, two federal lawsuits have been filed:
* The first one came from the Mackinac Center for Public Policy, hours after polls closed. Mackinac Center is a conservative think tank in Midland, Michigan. They're not challenging the ban on spending, but are instead challenging Prop 2's disclosure rules, asserting that mandatory disclosure of who has paid for political campaigns violates the First Amendment and violates privacy.
* The second court challenge carries more weight and is from DTE, Consumers, and their political action committees. Their complaint alleges that banning campaign contributions from organizations that represent one side of a political argument--while allowing contributions from organizations on the other side of the issue--violates free speech laws, and they want the ban thrown out.
Not deterred, proponents of Proposal 2 have been bracing for legal challenges since the drafting of the proposal and are confident it will hold up in court. "The language of Proposal 2 was carefully crafted with constitutionality in mind, and we are well prepared for this expected legal challenge," explained Samuel Bagenstos, a lawyer representing the organizations behind Proposal 2. "We intend to vigorously defend the will of Michiganders who overwhelmingly approved this measure."
* * *
Nicholas Jansen is Groundwork's Rural Clean Energy Organizer.
* * *
Original text here: https://groundworkcenter.org/whats-possible-in-the-wake-of-mop-up-ballot-passing/
[Category: Sociological]
* * *
What's possible in the wake of MOP UP ballot passing?
November 20, 2026
AUTHOR: Nicholas Jansen
In the midst of a midterm election that set all-time highs for spending by corporations and dark money political action committees, Michigan took its first step toward getting money out of politics. Proposal 2, approved on November 3 by 80% of voters, restricts campaign donations from utilities and government contractors that have contracts with the state worth over $250,000. While this ... Show Full Article TRAVERSE CITY, Michigan, Nov. 21 -- Groundwork Center for Resilient Communities issued the following news: * * * What's possible in the wake of MOP UP ballot passing? November 20, 2026 AUTHOR: Nicholas Jansen In the midst of a midterm election that set all-time highs for spending by corporations and dark money political action committees, Michigan took its first step toward getting money out of politics. Proposal 2, approved on November 3 by 80% of voters, restricts campaign donations from utilities and government contractors that have contracts with the state worth over $250,000. While thisis a relatively narrow scope, Prop 2 is a meaningful step toward rebuilding trust between Michiganders and their leaders.
And in Michigan, rebuilding trust is crucial, as our state government ranks 48th nationally in government transparency--in part because of the influence money has in our elections and lobbying efforts. Take for example the 2026 midterm election campaigns, in which about $767 million was spent on political advertising, ranking the state fourth-highest nationally. Corporations, wealthy individuals, and dark money groups understand their buying power. Time and time again they've put it to use trying to sway our elections and then tilt legislative policies their way. For instance, DTE and Consumers Energy spent a combined $215,000 to stop Proposal 2, and meanwhile they have donated to 92% of the current state legislative members. That kind of influence is not working for everyday Michiganders, who pay some of the highest electric rates in the nation while experiencing some of the most frequent and prolonged power outages.
Removing corporate influence is crucial, as Christy McGillivray from Voters Not Politicians, which sponsored the Proposal 2 ballot initiative, shared, "This is a long-game of building a shared sense of reality by uniting over a shared commitment of fighting corruption." When looking at the concerns over data centers, bitcoin mines, and flock cameras, we know Big Tech is also pumping money into our state legislature. This is a great first step at restoring power to the people, but we are not done!
Regarding dirty and unreliable energy in Michigan, what can we do now that Prop 2 has passed, and utility influence-spending is cut off? There have been a number of bills introduced in Michigan's legislature the past few years that were designed to combat rising prices and grid instability, but they failed, in large part, due to utility opposition and influence. We now have a favorable landscape where we can pass laws to promote proven technologies, such as virtual power plants, community solar, and plug-in solar, to help lower electricity cost while also strengthening our grid.
Proposal 2 opens the door for much good change. But, not surprisingly, the utilities and others who must curtail their political spending are pushing back. Thus far, two federal lawsuits have been filed:
* The first one came from the Mackinac Center for Public Policy, hours after polls closed. Mackinac Center is a conservative think tank in Midland, Michigan. They're not challenging the ban on spending, but are instead challenging Prop 2's disclosure rules, asserting that mandatory disclosure of who has paid for political campaigns violates the First Amendment and violates privacy.
* The second court challenge carries more weight and is from DTE, Consumers, and their political action committees. Their complaint alleges that banning campaign contributions from organizations that represent one side of a political argument--while allowing contributions from organizations on the other side of the issue--violates free speech laws, and they want the ban thrown out.
Not deterred, proponents of Proposal 2 have been bracing for legal challenges since the drafting of the proposal and are confident it will hold up in court. "The language of Proposal 2 was carefully crafted with constitutionality in mind, and we are well prepared for this expected legal challenge," explained Samuel Bagenstos, a lawyer representing the organizations behind Proposal 2. "We intend to vigorously defend the will of Michiganders who overwhelmingly approved this measure."
* * *
Nicholas Jansen is Groundwork's Rural Clean Energy Organizer.
* * *
Original text here: https://groundworkcenter.org/whats-possible-in-the-wake-of-mop-up-ballot-passing/
[Category: Sociological]
Children's Health Defense Issues Commentary: Politico's Deals With Drug and Chemical Industry Sponsors Draw Scrutiny
FRANKLIN LAKES, New Jersey, Nov. 21 [Category: Health Care] -- Children's Health Defense, an organization that says it restores and protects the health of children by eliminating exposures to environmental toxins, issued the following commentary by Henrick Karoliszyn, investigative reporter for The Defender:
* * *
Politico's Deals With Drug and Chemical Industry Sponsors Draw Scrutiny
MAHA Action President Tony Lyons says Politico's financial relationships with chemical giant Bayer, biopharma company Gilead Sciences and the American Chemistry Council threaten the outlet's credibility when covering ... Show Full Article FRANKLIN LAKES, New Jersey, Nov. 21 [Category: Health Care] -- Children's Health Defense, an organization that says it restores and protects the health of children by eliminating exposures to environmental toxins, issued the following commentary by Henrick Karoliszyn, investigative reporter for The Defender: * * * Politico's Deals With Drug and Chemical Industry Sponsors Draw Scrutiny MAHA Action President Tony Lyons says Politico's financial relationships with chemical giant Bayer, biopharma company Gilead Sciences and the American Chemistry Council threaten the outlet's credibility when coveringthe MAHA movement. "Politico has a conflict of interest," Lyons wrote. The publication maintains that its journalism is independent.
November 20, 2026
Pharmaceutical and chemical companies are paying Politico to sponsor articles, newsletters and events targeting Washington policymakers, prompting concerns about corporate influence on the news outlet's coverage of those same industries, according to MAHA Action President Tony Lyons.
In a recent commentary in The MAHA Report, Lyons accused Politico of accepting money from corporations seeking to influence federal health and environmental policies while publishing critical coverage of the Make America Healthy Again (MAHA) movement.
Lyons identified Bayer, Gilead Sciences, Danone, the American Chemistry Council and Pharmaceutical Research and Manufacturers of America (PhRMA) as companies and industry trade groups that have sponsored Politico content or initiatives.
"Politico has a conflict of interest," Lyons wrote. He argued that the financial relationships deserve further investigation.
Bayer's sponsorship draws scrutiny
Lyons singled out Bayer, the German pharmaceutical and agricultural chemical company that acquired Monsanto, maker of Roundup weedkiller.
According to Lyons, Bayer sponsored a multiyear Politico marketing campaign -- "Drive Sustainable Progress" -- designed to promote the company's policy priorities to lawmakers and government officials.
He said the campaign sought to reach elected officials as they developed their 2025 policy agendas.
Bayer has also sought federal protections against lawsuits alleging that its glyphosate-based Roundup herbicide causes cancer. The company maintains that glyphosate is safe when used according to label directions and disputes allegations that Roundup causes cancer.
In March 2015, the World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans."
Lyons argued that Bayer's sponsorship of Politico deserves scrutiny because the company has a direct financial interest in government decisions affecting pesticides.
Bayer told The Defender it could not comment on "individual expenditures or specific commercial arrangements" but that "transparency is a top priority for Bayer."
"More broadly, we are committed to strengthening trust by making information about our political engagement accessible. Our report on political advocacy describes our activities and avenues of engagement and provides disclosures on expenditures and key advocacy topics in our five largest markets. Bayer also has a Code of Conduct for Responsible Lobbying, which sets binding rules for our involvement in political matters and is designed to create transparency in our interactions with representatives of political institutions."
Politico sells regulatory intelligence to industries it covers
Politico's business relationships extend beyond advertising and sponsored events -- the news outlet's AgencyIQ division provides regulatory intelligence, analysis and data to help organizations monitor and understand regulatory developments.
According to its website, the AgencyIQ division helps companies understand and engage regulators, using analysis, data and journalism to support their work -- and that raises questions about the relationship between Politico's commercial services and its reporting on federal agencies, including the U.S. Food and Drug Administration.
In a 2015 interview with Digiday, Stephanie Losee, then head of Politico's branded content operation, described how money brought in by advertisers can help fund more journalism for readers.
"We chose the term 'brand journalism' very deliberately," Losee told the outlet. "We're not saying we are going to publish investigative pieces; what we mean is that brands and organizations can and should be using their budgets to commission more journalism."
Politico's goals often included changing public perceptions or influencing policy, she said.
The American Chemistry Council was among the trade associations identified in that reporting as a Politico advertising client. The company did not respond to The Defender's request for comment.
More recently, a 2026 investigation by Rapporteur examined Politico's European events business.
The investigation reported that sponsorship packages advertised to companies ranged from 35,000 to 85,000 euros ($38,441 to $93,356) and could include speaking opportunities, curated guest lists and interviews.
Politico, owned by German media company Axel Springer, also sells sponsored content to corporations:
"The content will be identified as 'sponsor-generated content' anywhere it may appear on the website. POLITICO's editorial department has no involvement in the creation of this content."
Both Politico and Axel Springer could not be reached for comment.
Critics raise concerns, Politico defends editorial independence
Who bankrolls information that influences public health policy? How does it affect which stories get published? And are there any biases?
Transparency International U.S. (TI US), a nonpartisan nonprofit organization that combats corruption in the U.S. and abroad through research, advocacy and efforts to strengthen government accountability, told The Defender that clarity is paramount to answering these questions.
TI US Executive Director Gary Kalman said the "media has a special role in our democracy and should be as transparent as they ask of the politicians they are covering. Any paid content should be clearly labeled/identified as such."
Other experts warned that media ties to pharmaceutical companies in particular could ultimately affect children.
"What particularly concerns me is the potential impact on children's health," said pediatrician Michelle Perro. "We cannot afford to have these conversations influenced primarily by the industries whose products and practices warrant investigations."
Politico has previously rejected allegations that its commercial relationships compromise its journalism.
In a February 2025 statement, CEO Goli Sheikholeslami and Editor-in-Chief John Harris said the company's public journalism is supported by advertising and sponsorships, while professional subscription services provide policy information to private businesses and government agencies.
The executives rejected claims that government subscriptions amounted to subsidies or created a hidden agenda.
"Government agencies that subscribe do so through standard public procurement processes -- just like any other tool they buy to work smarter and be more efficient," they wrote. "This is not funding. It is a transaction -- just as the government buys research, equipment, software and industry reports."
Politico has also said it maintains separation between its advertising and editorial operations.
A 'label doesn't make that conflict go away'
Lyons argued that labeling corporate material as sponsored does not resolve broader questions about conflicts of interest.
"A 'sponsored content or discussion' label doesn't make that conflict go away," he wrote.
His criticism comes as pharmaceutical and chemical companies face growing scrutiny over their influence on federal health policy, pesticide regulation and public perceptions of chronic disease.
Although Politico's financial relationships with industry sponsors are documented, evidence reviewed for this article did not establish that sponsors directed the news outlet's editorial coverage or that corporate payments influenced Politico's reporting on MAHA.
Still, for some, the outlet's financial arrangements remain a concern.
"Ultimately, this is not a political party issue, nor should it be reduced to a dispute over MAHA," said Perro. "It is about the integrity of the information upon which our children's health and our nation's public health policies depend," she said.
"The public deserves journalism that investigates powerful interests, not journalism whose independence must be taken on faith."
Related articles in The Defender
* Amid Threats of Lawsuits, Calley Means Stands By Claims That Corporate Corruption Tanked Some MAHA Initiatives (https://childrenshealthdefense.org/defender/amid-threats-lawsuits-calley-means-stands-by-claims-corporate-corruption-tanked-maha-initiatives/)
* Susie Wiles, Corporate Lobbyists Derailed Key MAHA Reforms, Calley Means Tells Joe Rogan (https://childrenshealthdefense.org/defender/susie-wiles-corporate-lobbyists-derailed-key-maha-reforms-calley-means-tells-joe-rogan/)
* Pharma Spent Record $456.9 Million Last Year on Lobbying -- With No Signs of Slowing Down (https://childrenshealthdefense.org/defender/big-pharma-lobbying-record-2025-no-signs-slowing-down/)
* MAHA: A Who's Who of Groups That Bear the 'Make America Healthy Again' Slogan in Their Names (https://childrenshealthdefense.org/defender/maha-whos-who-of-groups-make-america-healthy-again-slogan-name/)
* FDA Insiders Accuse Top Official of Leaking Information That 'Kneecapped' RFK Jr.'s Vaccine Agenda (https://childrenshealthdefense.org/defender/fda-top-official-david-kaslow-accused-leaking-info-crippling-rfk-jr-vaccine-agenda/)
* MAHA Commission Outlines Sweeping Agenda to Target Chronic Disease (https://childrenshealthdefense.org/defender/maha-commission-outlines-sweeping-agenda-to-target-chronic-disease/)
* Midterm Voters Deliver Mix of Wins, Losses to MAHA, Health Freedom Movements (https://childrenshealthdefense.org/defender/midterm-voters-deliver-mix-wins-losses-maha-health-freedom-movement/)
* * *
Henrick Karoliszyn, DSW, is an investigative reporter for The Defender.
* * *
Original text here: https://childrenshealthdefense.org/defender/politico-pharma-and-chemical-industry-sponsors-draw-scrutiny-maha/
* * *
Politico's Deals With Drug and Chemical Industry Sponsors Draw Scrutiny
MAHA Action President Tony Lyons says Politico's financial relationships with chemical giant Bayer, biopharma company Gilead Sciences and the American Chemistry Council threaten the outlet's credibility when covering ... Show Full Article FRANKLIN LAKES, New Jersey, Nov. 21 [Category: Health Care] -- Children's Health Defense, an organization that says it restores and protects the health of children by eliminating exposures to environmental toxins, issued the following commentary by Henrick Karoliszyn, investigative reporter for The Defender: * * * Politico's Deals With Drug and Chemical Industry Sponsors Draw Scrutiny MAHA Action President Tony Lyons says Politico's financial relationships with chemical giant Bayer, biopharma company Gilead Sciences and the American Chemistry Council threaten the outlet's credibility when coveringthe MAHA movement. "Politico has a conflict of interest," Lyons wrote. The publication maintains that its journalism is independent.
November 20, 2026
Pharmaceutical and chemical companies are paying Politico to sponsor articles, newsletters and events targeting Washington policymakers, prompting concerns about corporate influence on the news outlet's coverage of those same industries, according to MAHA Action President Tony Lyons.
In a recent commentary in The MAHA Report, Lyons accused Politico of accepting money from corporations seeking to influence federal health and environmental policies while publishing critical coverage of the Make America Healthy Again (MAHA) movement.
Lyons identified Bayer, Gilead Sciences, Danone, the American Chemistry Council and Pharmaceutical Research and Manufacturers of America (PhRMA) as companies and industry trade groups that have sponsored Politico content or initiatives.
"Politico has a conflict of interest," Lyons wrote. He argued that the financial relationships deserve further investigation.
Bayer's sponsorship draws scrutiny
Lyons singled out Bayer, the German pharmaceutical and agricultural chemical company that acquired Monsanto, maker of Roundup weedkiller.
According to Lyons, Bayer sponsored a multiyear Politico marketing campaign -- "Drive Sustainable Progress" -- designed to promote the company's policy priorities to lawmakers and government officials.
He said the campaign sought to reach elected officials as they developed their 2025 policy agendas.
Bayer has also sought federal protections against lawsuits alleging that its glyphosate-based Roundup herbicide causes cancer. The company maintains that glyphosate is safe when used according to label directions and disputes allegations that Roundup causes cancer.
In March 2015, the World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans."
Lyons argued that Bayer's sponsorship of Politico deserves scrutiny because the company has a direct financial interest in government decisions affecting pesticides.
Bayer told The Defender it could not comment on "individual expenditures or specific commercial arrangements" but that "transparency is a top priority for Bayer."
"More broadly, we are committed to strengthening trust by making information about our political engagement accessible. Our report on political advocacy describes our activities and avenues of engagement and provides disclosures on expenditures and key advocacy topics in our five largest markets. Bayer also has a Code of Conduct for Responsible Lobbying, which sets binding rules for our involvement in political matters and is designed to create transparency in our interactions with representatives of political institutions."
Politico sells regulatory intelligence to industries it covers
Politico's business relationships extend beyond advertising and sponsored events -- the news outlet's AgencyIQ division provides regulatory intelligence, analysis and data to help organizations monitor and understand regulatory developments.
According to its website, the AgencyIQ division helps companies understand and engage regulators, using analysis, data and journalism to support their work -- and that raises questions about the relationship between Politico's commercial services and its reporting on federal agencies, including the U.S. Food and Drug Administration.
In a 2015 interview with Digiday, Stephanie Losee, then head of Politico's branded content operation, described how money brought in by advertisers can help fund more journalism for readers.
"We chose the term 'brand journalism' very deliberately," Losee told the outlet. "We're not saying we are going to publish investigative pieces; what we mean is that brands and organizations can and should be using their budgets to commission more journalism."
Politico's goals often included changing public perceptions or influencing policy, she said.
The American Chemistry Council was among the trade associations identified in that reporting as a Politico advertising client. The company did not respond to The Defender's request for comment.
More recently, a 2026 investigation by Rapporteur examined Politico's European events business.
The investigation reported that sponsorship packages advertised to companies ranged from 35,000 to 85,000 euros ($38,441 to $93,356) and could include speaking opportunities, curated guest lists and interviews.
Politico, owned by German media company Axel Springer, also sells sponsored content to corporations:
"The content will be identified as 'sponsor-generated content' anywhere it may appear on the website. POLITICO's editorial department has no involvement in the creation of this content."
Both Politico and Axel Springer could not be reached for comment.
Critics raise concerns, Politico defends editorial independence
Who bankrolls information that influences public health policy? How does it affect which stories get published? And are there any biases?
Transparency International U.S. (TI US), a nonpartisan nonprofit organization that combats corruption in the U.S. and abroad through research, advocacy and efforts to strengthen government accountability, told The Defender that clarity is paramount to answering these questions.
TI US Executive Director Gary Kalman said the "media has a special role in our democracy and should be as transparent as they ask of the politicians they are covering. Any paid content should be clearly labeled/identified as such."
Other experts warned that media ties to pharmaceutical companies in particular could ultimately affect children.
"What particularly concerns me is the potential impact on children's health," said pediatrician Michelle Perro. "We cannot afford to have these conversations influenced primarily by the industries whose products and practices warrant investigations."
Politico has previously rejected allegations that its commercial relationships compromise its journalism.
In a February 2025 statement, CEO Goli Sheikholeslami and Editor-in-Chief John Harris said the company's public journalism is supported by advertising and sponsorships, while professional subscription services provide policy information to private businesses and government agencies.
The executives rejected claims that government subscriptions amounted to subsidies or created a hidden agenda.
"Government agencies that subscribe do so through standard public procurement processes -- just like any other tool they buy to work smarter and be more efficient," they wrote. "This is not funding. It is a transaction -- just as the government buys research, equipment, software and industry reports."
Politico has also said it maintains separation between its advertising and editorial operations.
A 'label doesn't make that conflict go away'
Lyons argued that labeling corporate material as sponsored does not resolve broader questions about conflicts of interest.
"A 'sponsored content or discussion' label doesn't make that conflict go away," he wrote.
His criticism comes as pharmaceutical and chemical companies face growing scrutiny over their influence on federal health policy, pesticide regulation and public perceptions of chronic disease.
Although Politico's financial relationships with industry sponsors are documented, evidence reviewed for this article did not establish that sponsors directed the news outlet's editorial coverage or that corporate payments influenced Politico's reporting on MAHA.
Still, for some, the outlet's financial arrangements remain a concern.
"Ultimately, this is not a political party issue, nor should it be reduced to a dispute over MAHA," said Perro. "It is about the integrity of the information upon which our children's health and our nation's public health policies depend," she said.
"The public deserves journalism that investigates powerful interests, not journalism whose independence must be taken on faith."
Related articles in The Defender
* Amid Threats of Lawsuits, Calley Means Stands By Claims That Corporate Corruption Tanked Some MAHA Initiatives (https://childrenshealthdefense.org/defender/amid-threats-lawsuits-calley-means-stands-by-claims-corporate-corruption-tanked-maha-initiatives/)
* Susie Wiles, Corporate Lobbyists Derailed Key MAHA Reforms, Calley Means Tells Joe Rogan (https://childrenshealthdefense.org/defender/susie-wiles-corporate-lobbyists-derailed-key-maha-reforms-calley-means-tells-joe-rogan/)
* Pharma Spent Record $456.9 Million Last Year on Lobbying -- With No Signs of Slowing Down (https://childrenshealthdefense.org/defender/big-pharma-lobbying-record-2025-no-signs-slowing-down/)
* MAHA: A Who's Who of Groups That Bear the 'Make America Healthy Again' Slogan in Their Names (https://childrenshealthdefense.org/defender/maha-whos-who-of-groups-make-america-healthy-again-slogan-name/)
* FDA Insiders Accuse Top Official of Leaking Information That 'Kneecapped' RFK Jr.'s Vaccine Agenda (https://childrenshealthdefense.org/defender/fda-top-official-david-kaslow-accused-leaking-info-crippling-rfk-jr-vaccine-agenda/)
* MAHA Commission Outlines Sweeping Agenda to Target Chronic Disease (https://childrenshealthdefense.org/defender/maha-commission-outlines-sweeping-agenda-to-target-chronic-disease/)
* Midterm Voters Deliver Mix of Wins, Losses to MAHA, Health Freedom Movements (https://childrenshealthdefense.org/defender/midterm-voters-deliver-mix-wins-losses-maha-health-freedom-movement/)
* * *
Henrick Karoliszyn, DSW, is an investigative reporter for The Defender.
* * *
Original text here: https://childrenshealthdefense.org/defender/politico-pharma-and-chemical-industry-sponsors-draw-scrutiny-maha/
Children's Health Defense Issues Commentary: NIH Review of 55 Animal Studies Links Glyphosate to Lower Sperm Counts, Reduced Testosterone
FRANKLIN LAKES, New Jersey, Nov. 21 [Category: Health Care] -- Children's Health Defense, an organization that says it restores and protects the health of children by eliminating exposures to environmental toxins, issued the following commentary by Brenda Baletti, senior reporter for The Defender:
* * *
NIH Review of 55 Animal Studies Links Glyphosate to Lower Sperm Counts, Reduced Testosterone
NIH scientists analyzed the effects of glyphosate and glyphosate-based herbicides, and found strong evidence that the chemical used in Roundup and other widely used weedkillers was consistently associated ... Show Full Article FRANKLIN LAKES, New Jersey, Nov. 21 [Category: Health Care] -- Children's Health Defense, an organization that says it restores and protects the health of children by eliminating exposures to environmental toxins, issued the following commentary by Brenda Baletti, senior reporter for The Defender: * * * NIH Review of 55 Animal Studies Links Glyphosate to Lower Sperm Counts, Reduced Testosterone NIH scientists analyzed the effects of glyphosate and glyphosate-based herbicides, and found strong evidence that the chemical used in Roundup and other widely used weedkillers was consistently associatedwith lower sperm counts, reduced sperm motility and increased numbers of abnormally shaped sperm. "I have long suspected that glyphosate is contributing to our current crisis in infertility," said MIT scientist Stephanie Seneff. "Glyphosate is an endocrine disruptor at very low exposure levels."
November 20, 2026
Glyphosate damages sperm health in lab animals and may interfere with testosterone production, according to a new National Institutes of Health (NIH) review.
NIH scientists, who analyzed 55 glyphosate toxicity studies in non-human mammals, said they found strong evidence that the chemical used in Roundup and other widely used weedkillers was consistently associated with lower sperm counts, reduced sperm motility and increased numbers of abnormally shaped sperm.
They also found evidence that glyphosate exposure reduced testosterone levels, particularly in juvenile and adult animals exposed for 30 days or longer.
The systematic review and meta-analysis, accepted for publication in the peer-reviewed Environment International on Nov. 9, was conducted by scientists from the NIH's Division of Translational Toxicology at the National Institute of Environmental Health Sciences.
The scientists analyzed the effects of glyphosate alone and of glyphosate-based herbicides (GBH), and concluded with high confidence that both had an overall negative effect on sperm health and sperm abundance. They said they were moderately confident that both also reduce testosterone.
They said the data provide a "biologically plausible hypothesis that glyphosate and GBH might affect male reproductive health of humans."
Glyphosate toxicity expert and MIT scientist Stephanie Seneff, Ph.D., told The Defender she was glad to see the study published.
"I have long suspected that glyphosate is contributing to our current crisis in infertility. I wrote about glyphosate's toxicity to sperm in my book 'Toxic Legacy,'" she said. "Glyphosate is an endocrine disruptor at very low exposure levels."
Seneff noted that there are also several other papers published in peer-reviewed journals such as Toxicology in Vitro, the International Journal of Environmental Research and Public Health and ACS Omega that weren't included in the study, but that also find links between glyphosate exposure and sperm and testicular damage.
Michael Antoniou, Ph.D., professor emeritus in molecular genetics and toxicology at King's College in London, who for years led a leading global research group investigating the health risks of glyphosate herbicides, told The Defender the NIH review was "well-executed."
Given that regulators regularly rely on toxicity studies from rats and mice, he said the findings are relevant to assessments of human health risk.
"Of greatest concern is the finding that both glyphosate and commercial GBH formulations showed negative male reproductive effects at doses that regulatory agencies in both the U.S. and the EU, as well as other countries across the world, deem safe to be ingested on a daily basis over a lifetime," Antoniou said.
"This adds to a growing body of evidence that current regulatory-set safety limits of exposure to this pesticide should be lowered," he added.
Children's Health Defense Senior Research Scientist Karl Jablonowski said the review adds to persistent evidence that glyphosate is a hormone disruptor with implications for fertility in humans.
"In this context, what is warranted is precaution -- which is an impetus of action, not an impetus to wait-and-see," he said.
Both glyphosate and GBH lowered testosterone levels
Several of the studies reviewed by NIH scientists identified adverse reproductive effects at doses overlapping with exposure limits established by U.S. and European regulators. They reported reproductive effects at doses as low as 0.5 milligrams per kilogram (mg/kg) body weight per day.
The European Food Safety Authority has established an acceptable daily intake of 0.5 mg/kg per day, while the U.S. Environmental Protection Agency's (EPA) reference dose is 1.75 mg/kg per day.
For the study, the authors searched PubMed, Web of Science, Scopus and the Chinese databases CNKI and Wanfang through April 2026, narrowing more than 19,000 references to 55 eligible studies.
For glyphosate alone, 10 of 11 studies addressing the three main sperm issues found damage to sperm health. For GBH, 16 of 18 studies reported higher percentages of abnormal sperm, 12 of 14 reported reduced motility, and 13 of 17 reported reduced sperm count.
Researchers found that the effects were most consistent when exposure lasted 30 days or more, which is the approximate amount of time necessary for a full sperm production cycle in the animals studied.
They also found evidence that both glyphosate and GBH lowered testosterone levels, particularly when animals were exposed as juveniles or adults -- rather than in vitro.
Seven of 12 glyphosate studies marked this trend, and 13 of 23 GBH studies also found significant decreases in testosterone levels.
"The main driver for most outcomes was the glyphosate, as animals exposed to glyphosate alone consistently showed comparable adverse effects with those exposed to the GBH formulations," Antoniou said.
However, he noted that the GBH formulations had a greater effect on sperm motility and morphology than glyphosate alone, suggesting "that the co-formulants play an important role in harming sperm," he said.
"The real outcomes are probably worse than what is reported in this review because the relevant industry data were not available in full for scrutiny by the authors," Antoniou added.
Glyphosate exposure is widespread
Due to widespread exposure, most Americans have detectable levels of glyphosate present in their urine, according to the Centers for Disease Control and Prevention (CDC).
People are exposed to glyphosate through food, drinking water, skin contact, and inhalation of airborne particles.
The toxin is present on fruits and vegetables and in higher concentrations on foods that retain residue, particularly grains and legumes.
Farmers who apply the chemical to crops have glyphosate present in their bodies at higher levels. However, studies have also found glyphosate in dust in non-agricultural homes.
A French study in 2024 found glyphosate present in 55% of sperm samples from an infertility clinic.
Last year, a major scientific study that regulators around the world relied on for decades to justify continued approval of glyphosate was quietly retracted over serious ethical issues -- including secret authorship by Monsanto employees -- raising questions about the pesticide-approval process in the U.S. and globally.
In March 2015, the World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans."
Three days left to submit glyphosate comments to EPA
The EPA is updating its human health risk assessment and evaluation of glyphosate's carcinogenic potential. As part of the process, the agency made its open literature review available for public comment.
Typically, when the EPA reviews a pesticide, it relies largely on confidential data sponsored and submitted by chemical companies.
However, glyphosate has been extensively studied by scientists globally with results published in scientific literature. That body of independent research is called "open literature."
The EPA released a document describing how it plans to do the systematic review and presenting a list of publications in the open literature collected since the agency's last review in 2017.
In September, the EPA extended the deadline for public comment by 60 days, encouraging researchers, farmers, families, and every stakeholder from the general public to submit evidence they think ought to be considered.
For example, Antoniou submitted a comment encouraging the EPA to consider the nearly 1,000 studies on glyphosate/GBH's health and environmental effects that have been published in the last 12 months alone and to abandon its use of the retracted study.
The deadline to submit comments at Regulations.gov is Nov. 23.
Related articles in The Defender
* 'Serious Ethical Concerns': Journal Retracts Key Glyphosate Safety Study, Allegedly Ghostwritten by Monsanto (https://childrenshealthdefense.org/defender/journal-retracts-glyphosate-safety-study-allegedly-ghostwritten-monsanto-rtk/)
* Widely Used 'Chemical Cocktails' Tied to Gut Damage, Inflammation (https://childrenshealthdefense.org/defender/widely-used-chemical-cocktails-tied-to-gut-damage-inflammation-pesticides/)
* Glyphosate Present in 57% of Sperm Samples From Infertile Men (https://childrenshealthdefense.org/defender/glyphosate-monsanto-roundup-sperm-samples-infertile-men-cola/)
* Exposure to Glyphosate Could Harm Not Only You, But Your Kids and Grandkids, Too (https://childrenshealthdefense.org/defender/glyphosate-increased-disease-subsequent-generations/)
* 55% of Sperm Samples Contained High Levels of Glyphosate Weedkiller (https://childrenshealthdefense.org/defender/sperm-samples-contain-high-levels-glyphosate-weedkiller/)
* Glyphosate Causes Permanent Damage to Reproductive Organs, Affects Fertility (https://childrenshealthdefense.org/defender/glyphosate-permanent-damage-reproductive-organs-infertility-cola/)
* * *
Brenda Baletti, Ph.D., is a senior reporter for The Defender. She wrote and taught about capitalism and politics for 10 years in the writing program at Duke University. She holds a Ph.D. in human geography from the University of North Carolina at Chapel Hill and a master's from the University of Texas at Austin.
* * *
Original text here: https://childrenshealthdefense.org/defender/glyphosate-lower-sperm-count-reduced-testosterone-nih-review-55-animal-studies/
* * *
NIH Review of 55 Animal Studies Links Glyphosate to Lower Sperm Counts, Reduced Testosterone
NIH scientists analyzed the effects of glyphosate and glyphosate-based herbicides, and found strong evidence that the chemical used in Roundup and other widely used weedkillers was consistently associated ... Show Full Article FRANKLIN LAKES, New Jersey, Nov. 21 [Category: Health Care] -- Children's Health Defense, an organization that says it restores and protects the health of children by eliminating exposures to environmental toxins, issued the following commentary by Brenda Baletti, senior reporter for The Defender: * * * NIH Review of 55 Animal Studies Links Glyphosate to Lower Sperm Counts, Reduced Testosterone NIH scientists analyzed the effects of glyphosate and glyphosate-based herbicides, and found strong evidence that the chemical used in Roundup and other widely used weedkillers was consistently associatedwith lower sperm counts, reduced sperm motility and increased numbers of abnormally shaped sperm. "I have long suspected that glyphosate is contributing to our current crisis in infertility," said MIT scientist Stephanie Seneff. "Glyphosate is an endocrine disruptor at very low exposure levels."
November 20, 2026
Glyphosate damages sperm health in lab animals and may interfere with testosterone production, according to a new National Institutes of Health (NIH) review.
NIH scientists, who analyzed 55 glyphosate toxicity studies in non-human mammals, said they found strong evidence that the chemical used in Roundup and other widely used weedkillers was consistently associated with lower sperm counts, reduced sperm motility and increased numbers of abnormally shaped sperm.
They also found evidence that glyphosate exposure reduced testosterone levels, particularly in juvenile and adult animals exposed for 30 days or longer.
The systematic review and meta-analysis, accepted for publication in the peer-reviewed Environment International on Nov. 9, was conducted by scientists from the NIH's Division of Translational Toxicology at the National Institute of Environmental Health Sciences.
The scientists analyzed the effects of glyphosate alone and of glyphosate-based herbicides (GBH), and concluded with high confidence that both had an overall negative effect on sperm health and sperm abundance. They said they were moderately confident that both also reduce testosterone.
They said the data provide a "biologically plausible hypothesis that glyphosate and GBH might affect male reproductive health of humans."
Glyphosate toxicity expert and MIT scientist Stephanie Seneff, Ph.D., told The Defender she was glad to see the study published.
"I have long suspected that glyphosate is contributing to our current crisis in infertility. I wrote about glyphosate's toxicity to sperm in my book 'Toxic Legacy,'" she said. "Glyphosate is an endocrine disruptor at very low exposure levels."
Seneff noted that there are also several other papers published in peer-reviewed journals such as Toxicology in Vitro, the International Journal of Environmental Research and Public Health and ACS Omega that weren't included in the study, but that also find links between glyphosate exposure and sperm and testicular damage.
Michael Antoniou, Ph.D., professor emeritus in molecular genetics and toxicology at King's College in London, who for years led a leading global research group investigating the health risks of glyphosate herbicides, told The Defender the NIH review was "well-executed."
Given that regulators regularly rely on toxicity studies from rats and mice, he said the findings are relevant to assessments of human health risk.
"Of greatest concern is the finding that both glyphosate and commercial GBH formulations showed negative male reproductive effects at doses that regulatory agencies in both the U.S. and the EU, as well as other countries across the world, deem safe to be ingested on a daily basis over a lifetime," Antoniou said.
"This adds to a growing body of evidence that current regulatory-set safety limits of exposure to this pesticide should be lowered," he added.
Children's Health Defense Senior Research Scientist Karl Jablonowski said the review adds to persistent evidence that glyphosate is a hormone disruptor with implications for fertility in humans.
"In this context, what is warranted is precaution -- which is an impetus of action, not an impetus to wait-and-see," he said.
Both glyphosate and GBH lowered testosterone levels
Several of the studies reviewed by NIH scientists identified adverse reproductive effects at doses overlapping with exposure limits established by U.S. and European regulators. They reported reproductive effects at doses as low as 0.5 milligrams per kilogram (mg/kg) body weight per day.
The European Food Safety Authority has established an acceptable daily intake of 0.5 mg/kg per day, while the U.S. Environmental Protection Agency's (EPA) reference dose is 1.75 mg/kg per day.
For the study, the authors searched PubMed, Web of Science, Scopus and the Chinese databases CNKI and Wanfang through April 2026, narrowing more than 19,000 references to 55 eligible studies.
For glyphosate alone, 10 of 11 studies addressing the three main sperm issues found damage to sperm health. For GBH, 16 of 18 studies reported higher percentages of abnormal sperm, 12 of 14 reported reduced motility, and 13 of 17 reported reduced sperm count.
Researchers found that the effects were most consistent when exposure lasted 30 days or more, which is the approximate amount of time necessary for a full sperm production cycle in the animals studied.
They also found evidence that both glyphosate and GBH lowered testosterone levels, particularly when animals were exposed as juveniles or adults -- rather than in vitro.
Seven of 12 glyphosate studies marked this trend, and 13 of 23 GBH studies also found significant decreases in testosterone levels.
"The main driver for most outcomes was the glyphosate, as animals exposed to glyphosate alone consistently showed comparable adverse effects with those exposed to the GBH formulations," Antoniou said.
However, he noted that the GBH formulations had a greater effect on sperm motility and morphology than glyphosate alone, suggesting "that the co-formulants play an important role in harming sperm," he said.
"The real outcomes are probably worse than what is reported in this review because the relevant industry data were not available in full for scrutiny by the authors," Antoniou added.
Glyphosate exposure is widespread
Due to widespread exposure, most Americans have detectable levels of glyphosate present in their urine, according to the Centers for Disease Control and Prevention (CDC).
People are exposed to glyphosate through food, drinking water, skin contact, and inhalation of airborne particles.
The toxin is present on fruits and vegetables and in higher concentrations on foods that retain residue, particularly grains and legumes.
Farmers who apply the chemical to crops have glyphosate present in their bodies at higher levels. However, studies have also found glyphosate in dust in non-agricultural homes.
A French study in 2024 found glyphosate present in 55% of sperm samples from an infertility clinic.
Last year, a major scientific study that regulators around the world relied on for decades to justify continued approval of glyphosate was quietly retracted over serious ethical issues -- including secret authorship by Monsanto employees -- raising questions about the pesticide-approval process in the U.S. and globally.
In March 2015, the World Health Organization's International Agency for Research on Cancer classified glyphosate as "probably carcinogenic to humans."
Three days left to submit glyphosate comments to EPA
The EPA is updating its human health risk assessment and evaluation of glyphosate's carcinogenic potential. As part of the process, the agency made its open literature review available for public comment.
Typically, when the EPA reviews a pesticide, it relies largely on confidential data sponsored and submitted by chemical companies.
However, glyphosate has been extensively studied by scientists globally with results published in scientific literature. That body of independent research is called "open literature."
The EPA released a document describing how it plans to do the systematic review and presenting a list of publications in the open literature collected since the agency's last review in 2017.
In September, the EPA extended the deadline for public comment by 60 days, encouraging researchers, farmers, families, and every stakeholder from the general public to submit evidence they think ought to be considered.
For example, Antoniou submitted a comment encouraging the EPA to consider the nearly 1,000 studies on glyphosate/GBH's health and environmental effects that have been published in the last 12 months alone and to abandon its use of the retracted study.
The deadline to submit comments at Regulations.gov is Nov. 23.
Related articles in The Defender
* 'Serious Ethical Concerns': Journal Retracts Key Glyphosate Safety Study, Allegedly Ghostwritten by Monsanto (https://childrenshealthdefense.org/defender/journal-retracts-glyphosate-safety-study-allegedly-ghostwritten-monsanto-rtk/)
* Widely Used 'Chemical Cocktails' Tied to Gut Damage, Inflammation (https://childrenshealthdefense.org/defender/widely-used-chemical-cocktails-tied-to-gut-damage-inflammation-pesticides/)
* Glyphosate Present in 57% of Sperm Samples From Infertile Men (https://childrenshealthdefense.org/defender/glyphosate-monsanto-roundup-sperm-samples-infertile-men-cola/)
* Exposure to Glyphosate Could Harm Not Only You, But Your Kids and Grandkids, Too (https://childrenshealthdefense.org/defender/glyphosate-increased-disease-subsequent-generations/)
* 55% of Sperm Samples Contained High Levels of Glyphosate Weedkiller (https://childrenshealthdefense.org/defender/sperm-samples-contain-high-levels-glyphosate-weedkiller/)
* Glyphosate Causes Permanent Damage to Reproductive Organs, Affects Fertility (https://childrenshealthdefense.org/defender/glyphosate-permanent-damage-reproductive-organs-infertility-cola/)
* * *
Brenda Baletti, Ph.D., is a senior reporter for The Defender. She wrote and taught about capitalism and politics for 10 years in the writing program at Duke University. She holds a Ph.D. in human geography from the University of North Carolina at Chapel Hill and a master's from the University of Texas at Austin.
* * *
Original text here: https://childrenshealthdefense.org/defender/glyphosate-lower-sperm-count-reduced-testosterone-nih-review-55-animal-studies/
Children's Health Defense Issues Commentary: 'This Is Not Living' - Doctors Told Her to Avoid MRNA COVID Vaccines. Then She Was Injured by Novavax
FRANKLIN LAKES, New Jersey, Nov. 21 [Category: Health Care] -- Children's Health Defense, an organization that says it restores and protects the health of children by eliminating exposures to environmental toxins, issued the following commentary by Michael Nevradakis, senior reporter for The Defender:
* * *
'This Is Not Living': Doctors Told Her to Avoid mRNA COVID Vaccines. Then She Was Injured by Novavax
In 2022, Trina Jennings received two doses of the Novavax COVID-19 vaccine -- one in August and another in September. Then her life came crashing down. She experienced one of the worst migraines ... Show Full Article FRANKLIN LAKES, New Jersey, Nov. 21 [Category: Health Care] -- Children's Health Defense, an organization that says it restores and protects the health of children by eliminating exposures to environmental toxins, issued the following commentary by Michael Nevradakis, senior reporter for The Defender: * * * 'This Is Not Living': Doctors Told Her to Avoid mRNA COVID Vaccines. Then She Was Injured by Novavax In 2022, Trina Jennings received two doses of the Novavax COVID-19 vaccine -- one in August and another in September. Then her life came crashing down. She experienced one of the worst migrainesof her life after the first dose. Three weeks after her second dose, her legs grew progressively weaker. Within days, she could barely walk.
November 20, 2026
In 2022, Trina Jennings' career was thriving. She was a licensed massage therapist in Washington state, where she planned to expand her business to help her husband -- a disabled veteran -- ease into retirement.
Jennings was also a martial arts practitioner who worked out regularly and was in great health.
But after Jennings received two doses of the Novavax COVID-19 vaccine -- one in August 2022 and another a month later -- her life came crashing down. She experienced one of the worst migraines of her life after the first dose.
Three weeks after her second dose, her legs grew progressively weaker. Within days, she could barely walk.
Jennings soon developed severe neurological symptoms. Her primary care physician diagnosed her with Guillain-Barre syndrome (GBS), a neurological disorder affecting the peripheral nerves linked to the COVID-19 vaccines.
The diagnoses did not stop there. Jennings was later diagnosed with chronic fatigue syndrome and ischiofemoral impingement syndrome, a condition she believes is congenital but whose effects became substantially more debilitating following her vaccine injury.
Prolonged impairment and lack of treatment have led to significant muscle atrophy.
Jennings also experienced dizziness, fainting and episodes resembling mini-strokes, but those conditions have subsided. Yet despite this relative improvement, Jennings today is unable to work and has shuttered her business.
Instead of retiring, her husband now financially supports her and is her primary caregiver.
"I'm just completely bedridden, spend about 80%-90% of my day in bed," Jennings said. "My memory? Not so great anymore."
In an interview with The Defender, Jennings said her vaccine injuries and gaslighting by physicians compounded the mental health toll of the "vitriol" she faced while waiting, on medical advice, for Novavax to become available.
She also described financial hardships stemming from the cost of her care and denial of her disability insurance claim.
Injured despite taking a 'traditional' protein-based COVID vaccine
As a massage therapist, Washington state's COVID-19 policies required her to get vaccinated, as she was considered a healthcare provider. But three of her long-term physicians advised her to wait for the release of the non-mRNA Novavax COVID-19 vaccine -- a "traditional" protein-based vaccine -- based on prior health issues.
"I have a very strange relationship, to put it mildly, with a lot of medications, as well as supplements, and I've always been that way," Jennings said. This included a history of allergies and adverse events linked to penicillin and ibuprofen.
Because of this history, physicians advised Jennings to forego the mRNA Pfizer and Moderna shots, as they were not recommended for people who have a history of allergies to medications.
Novavax wasn't approved in the U.S. until the summer of 2022. Jennings said that while she was prone to chronic migraines, what she experienced after her first dose of Novavax was "horrible -- one of the worst ones I'd ever had."
Because of her severe migraine, Jennings' primary care physician advised her to wait a bit longer for the second dose, so she got it after five weeks instead of three.
Three weeks after her second dose, Jennings recalled returning from a martial arts class, where she had practiced a form that she'd been working on "for about five years." This time, though, was different. "It was the first time I'd felt the form moving through me rather than me moving through the form," she said.
At first, Jennings recalled feeling "amazing" -- but the initial euphoria soon gave way to a troubling aftermath. "The weekend came, and my legs just started getting weaker and weaker," Jennings said. She thought she had perhaps "gone too hard" in class, but by early the following week, she could no longer move her legs.
An emergency room doctor "quietly" told Jennings that her injuries resembled GBS, but didn't note it in her records. Her primary care doctor later confirmed a GBS diagnosis.
Jennings was diagnosed with myalgic encephalomyelitis/chronic fatigue syndrome, a debilitating condition involving severe fatigue and other symptoms that can worsen following physical or mental exertion.
Earlier in her illness, attempting to remain upright sometimes caused fainting and symptoms resembling a transient ischemic attack, commonly called a mini-stroke.
Jennings said the combined effects of her injuries have made it nearly impossible to sit or stand for more than a few minutes. Even if she regained her ability to move freely, the chronic fatigue would prevent her from returning to her former lifestyle.
Visits to specialists fraught with instances of gaslighting
Her injuries were ultimately diagnosed, but Jennings said the process of getting answers was fraught with gaslighting.
"There was an allergist that I saw, and my GBS at that point was in full swing. It was obvious that I was having a lot of trouble moving. I had a cane with me, and the assistant asked me, 'How's everything going?'"
When Jennings explained that she'd been injured by a vaccine, the conversation took a different turn.
"All of a sudden, I mean, you can feel it's palpable -- the wall goes up, she gets all hostile toward me."
Jennings said she has consulted cardiologists, neurologists, a rheumatologist, a hematologist and other specialists as part of her search for answers. However, most appointments would end without meaningful treatment or explanations for her symptoms. On several occasions, she was simply told that she's "fine."
Eventually, Jennings became so discouraged she stopped seeking additional specialist consultations. "I just gave up. I didn't know what else to do," she said.
'I can't therapy my way into being able to sit and stand again'
Jennings said her efforts to secure Social Security Disability Insurance benefits have added another layer of stress -- one shared by many vaccine-injured people who have faced trouble getting insurance coverage for the treatments their injuries require.
She hired a lawyer when chronic migraines were already limiting her ability to work. But as her neurological symptoms developed and her condition worsened, she said she struggled to persuade the attorney to address the significant changes in her health.
Jennings' initial disability application was denied, followed by another denial on appeal. She then stopped hearing from her attorney and felt too overwhelmed to continue pursuing the case. "I just froze and didn't know what to do," she said.
Jennings said that as part of her treatment she learned that she had a congenital deformity called ischiofemoral impingement, or IFI syndrome. Although this condition likely exacerbated her injuries, it may have also contributed to the denial of her claim.
Jennings also learned that relying on a naturopath as her primary medical provider had likely complicated her application.
She said the denial of disability benefits contributed to her financial and mental health challenges, and that a part of her "died" when she was forced to close her business.
Her husband's health insurance through Boeing has provided her access to some treatments, including chiropractic care and acupuncture. Still, Jennings said the loss of her income, outstanding business debts and additional household needs have put the couple under considerable financial pressure.
"I'm still saddled with business debt that my husband is having to pay off," Jennings said.
Jennings said she is fortunate that her primary physician supports her and is treating her with vaccine injury protocols. She also found another doctor who, although skeptical of the vaccine connection, listened to her concerns and agreed to help document her disabilities. However, he plans to retire, leaving her unsure where to turn next.
Her doctors' support is little consolation for Jennings' day-to-day challenges though, as she said is "completely bedridden" and "physically can't go anywhere" as a result. She receives outside help from volunteers even for basic housekeeping tasks.
"I can't therapy my way into being able to sit and stand again," Jennings said. "This is not manageable, and this is not living."
Related articles in The Defender
* They Were Injured by Experimental Vaccines. Insurers Refuse to Cover Their Treatments (https://childrenshealthdefense.org/defender/injured-by-experimental-vaccines-insurers-refuse-to-cover-their-treatments/)
* COVID Vaccines Triggered Psychiatric Disorders, Including Suicides (https://childrenshealthdefense.org/defender/covid-vaccines-triggered-psychiatric-disorders-including-suicides-mental-health-issues/)
* Guillain-Barre Syndrome Associated With 17 Vaccines, Including COVID and Flu Shots (https://childrenshealthdefense.org/defender/guillain-barre-syndrome-covid-flu-vaccines/)
* FDA Authorizes 'Traditional' Novavax COVID Vaccine, But Critics Question Safety Claims (https://childrenshealthdefense.org/defender/fda-authorize-traditional-novavax-covid-vaccine-safety-claims/)
* What You Don't Know Could Hurt You: Novavax's 'Loud-and-Clear' Nanoparticle Adjuvant (https://childrenshealthdefense.org/defender/novavax-covid-vaccine-nanoparticle-adjuvant/)
* 'Seismic Shift': Medicare to Reimburse Doctors for Diagnosing, Treating Vaccine Injuries (https://childrenshealthdefense.org/defender/medicare-reimburse-doctors-vaccine-injury-diagnosis-treatment/)
* * *
Michael Nevradakis, Ph.D., based in Athens, Greece, is a senior reporter for The Defender.
* * *
Original text here: https://childrenshealthdefense.org/defender/doctors-said-avoid-mrna-covid-vaccines-novavax-injury-trina-jennings/
* * *
'This Is Not Living': Doctors Told Her to Avoid mRNA COVID Vaccines. Then She Was Injured by Novavax
In 2022, Trina Jennings received two doses of the Novavax COVID-19 vaccine -- one in August and another in September. Then her life came crashing down. She experienced one of the worst migraines ... Show Full Article FRANKLIN LAKES, New Jersey, Nov. 21 [Category: Health Care] -- Children's Health Defense, an organization that says it restores and protects the health of children by eliminating exposures to environmental toxins, issued the following commentary by Michael Nevradakis, senior reporter for The Defender: * * * 'This Is Not Living': Doctors Told Her to Avoid mRNA COVID Vaccines. Then She Was Injured by Novavax In 2022, Trina Jennings received two doses of the Novavax COVID-19 vaccine -- one in August and another in September. Then her life came crashing down. She experienced one of the worst migrainesof her life after the first dose. Three weeks after her second dose, her legs grew progressively weaker. Within days, she could barely walk.
November 20, 2026
In 2022, Trina Jennings' career was thriving. She was a licensed massage therapist in Washington state, where she planned to expand her business to help her husband -- a disabled veteran -- ease into retirement.
Jennings was also a martial arts practitioner who worked out regularly and was in great health.
But after Jennings received two doses of the Novavax COVID-19 vaccine -- one in August 2022 and another a month later -- her life came crashing down. She experienced one of the worst migraines of her life after the first dose.
Three weeks after her second dose, her legs grew progressively weaker. Within days, she could barely walk.
Jennings soon developed severe neurological symptoms. Her primary care physician diagnosed her with Guillain-Barre syndrome (GBS), a neurological disorder affecting the peripheral nerves linked to the COVID-19 vaccines.
The diagnoses did not stop there. Jennings was later diagnosed with chronic fatigue syndrome and ischiofemoral impingement syndrome, a condition she believes is congenital but whose effects became substantially more debilitating following her vaccine injury.
Prolonged impairment and lack of treatment have led to significant muscle atrophy.
Jennings also experienced dizziness, fainting and episodes resembling mini-strokes, but those conditions have subsided. Yet despite this relative improvement, Jennings today is unable to work and has shuttered her business.
Instead of retiring, her husband now financially supports her and is her primary caregiver.
"I'm just completely bedridden, spend about 80%-90% of my day in bed," Jennings said. "My memory? Not so great anymore."
In an interview with The Defender, Jennings said her vaccine injuries and gaslighting by physicians compounded the mental health toll of the "vitriol" she faced while waiting, on medical advice, for Novavax to become available.
She also described financial hardships stemming from the cost of her care and denial of her disability insurance claim.
Injured despite taking a 'traditional' protein-based COVID vaccine
As a massage therapist, Washington state's COVID-19 policies required her to get vaccinated, as she was considered a healthcare provider. But three of her long-term physicians advised her to wait for the release of the non-mRNA Novavax COVID-19 vaccine -- a "traditional" protein-based vaccine -- based on prior health issues.
"I have a very strange relationship, to put it mildly, with a lot of medications, as well as supplements, and I've always been that way," Jennings said. This included a history of allergies and adverse events linked to penicillin and ibuprofen.
Because of this history, physicians advised Jennings to forego the mRNA Pfizer and Moderna shots, as they were not recommended for people who have a history of allergies to medications.
Novavax wasn't approved in the U.S. until the summer of 2022. Jennings said that while she was prone to chronic migraines, what she experienced after her first dose of Novavax was "horrible -- one of the worst ones I'd ever had."
Because of her severe migraine, Jennings' primary care physician advised her to wait a bit longer for the second dose, so she got it after five weeks instead of three.
Three weeks after her second dose, Jennings recalled returning from a martial arts class, where she had practiced a form that she'd been working on "for about five years." This time, though, was different. "It was the first time I'd felt the form moving through me rather than me moving through the form," she said.
At first, Jennings recalled feeling "amazing" -- but the initial euphoria soon gave way to a troubling aftermath. "The weekend came, and my legs just started getting weaker and weaker," Jennings said. She thought she had perhaps "gone too hard" in class, but by early the following week, she could no longer move her legs.
An emergency room doctor "quietly" told Jennings that her injuries resembled GBS, but didn't note it in her records. Her primary care doctor later confirmed a GBS diagnosis.
Jennings was diagnosed with myalgic encephalomyelitis/chronic fatigue syndrome, a debilitating condition involving severe fatigue and other symptoms that can worsen following physical or mental exertion.
Earlier in her illness, attempting to remain upright sometimes caused fainting and symptoms resembling a transient ischemic attack, commonly called a mini-stroke.
Jennings said the combined effects of her injuries have made it nearly impossible to sit or stand for more than a few minutes. Even if she regained her ability to move freely, the chronic fatigue would prevent her from returning to her former lifestyle.
Visits to specialists fraught with instances of gaslighting
Her injuries were ultimately diagnosed, but Jennings said the process of getting answers was fraught with gaslighting.
"There was an allergist that I saw, and my GBS at that point was in full swing. It was obvious that I was having a lot of trouble moving. I had a cane with me, and the assistant asked me, 'How's everything going?'"
When Jennings explained that she'd been injured by a vaccine, the conversation took a different turn.
"All of a sudden, I mean, you can feel it's palpable -- the wall goes up, she gets all hostile toward me."
Jennings said she has consulted cardiologists, neurologists, a rheumatologist, a hematologist and other specialists as part of her search for answers. However, most appointments would end without meaningful treatment or explanations for her symptoms. On several occasions, she was simply told that she's "fine."
Eventually, Jennings became so discouraged she stopped seeking additional specialist consultations. "I just gave up. I didn't know what else to do," she said.
'I can't therapy my way into being able to sit and stand again'
Jennings said her efforts to secure Social Security Disability Insurance benefits have added another layer of stress -- one shared by many vaccine-injured people who have faced trouble getting insurance coverage for the treatments their injuries require.
She hired a lawyer when chronic migraines were already limiting her ability to work. But as her neurological symptoms developed and her condition worsened, she said she struggled to persuade the attorney to address the significant changes in her health.
Jennings' initial disability application was denied, followed by another denial on appeal. She then stopped hearing from her attorney and felt too overwhelmed to continue pursuing the case. "I just froze and didn't know what to do," she said.
Jennings said that as part of her treatment she learned that she had a congenital deformity called ischiofemoral impingement, or IFI syndrome. Although this condition likely exacerbated her injuries, it may have also contributed to the denial of her claim.
Jennings also learned that relying on a naturopath as her primary medical provider had likely complicated her application.
She said the denial of disability benefits contributed to her financial and mental health challenges, and that a part of her "died" when she was forced to close her business.
Her husband's health insurance through Boeing has provided her access to some treatments, including chiropractic care and acupuncture. Still, Jennings said the loss of her income, outstanding business debts and additional household needs have put the couple under considerable financial pressure.
"I'm still saddled with business debt that my husband is having to pay off," Jennings said.
Jennings said she is fortunate that her primary physician supports her and is treating her with vaccine injury protocols. She also found another doctor who, although skeptical of the vaccine connection, listened to her concerns and agreed to help document her disabilities. However, he plans to retire, leaving her unsure where to turn next.
Her doctors' support is little consolation for Jennings' day-to-day challenges though, as she said is "completely bedridden" and "physically can't go anywhere" as a result. She receives outside help from volunteers even for basic housekeeping tasks.
"I can't therapy my way into being able to sit and stand again," Jennings said. "This is not manageable, and this is not living."
Related articles in The Defender
* They Were Injured by Experimental Vaccines. Insurers Refuse to Cover Their Treatments (https://childrenshealthdefense.org/defender/injured-by-experimental-vaccines-insurers-refuse-to-cover-their-treatments/)
* COVID Vaccines Triggered Psychiatric Disorders, Including Suicides (https://childrenshealthdefense.org/defender/covid-vaccines-triggered-psychiatric-disorders-including-suicides-mental-health-issues/)
* Guillain-Barre Syndrome Associated With 17 Vaccines, Including COVID and Flu Shots (https://childrenshealthdefense.org/defender/guillain-barre-syndrome-covid-flu-vaccines/)
* FDA Authorizes 'Traditional' Novavax COVID Vaccine, But Critics Question Safety Claims (https://childrenshealthdefense.org/defender/fda-authorize-traditional-novavax-covid-vaccine-safety-claims/)
* What You Don't Know Could Hurt You: Novavax's 'Loud-and-Clear' Nanoparticle Adjuvant (https://childrenshealthdefense.org/defender/novavax-covid-vaccine-nanoparticle-adjuvant/)
* 'Seismic Shift': Medicare to Reimburse Doctors for Diagnosing, Treating Vaccine Injuries (https://childrenshealthdefense.org/defender/medicare-reimburse-doctors-vaccine-injury-diagnosis-treatment/)
* * *
Michael Nevradakis, Ph.D., based in Athens, Greece, is a senior reporter for The Defender.
* * *
Original text here: https://childrenshealthdefense.org/defender/doctors-said-avoid-mrna-covid-vaccines-novavax-injury-trina-jennings/
Appalachian Voices: Senate-passed Permitting Deal Benefits Corporate Polluters at Great Cost to Our Communities
BOONE, North Carolina, Nov. 21 [Category: Sociological] -- Appalachian Voices issued the following news release:
* * *
Senate-passed permitting deal benefits corporate polluters at great cost to our communities
November 20, 2026
WASHINGTON, D.C. -- Last night, the Senate passed the Bipartisan American Affordability and Jobs Act -- a permitting deal that attempts to eliminate some of our most important community and environmental protections in an effort to speed up the permitting of infrastructure projects. Despite some changes to the bill made through the manager's amendment, the version of ... Show Full Article BOONE, North Carolina, Nov. 21 [Category: Sociological] -- Appalachian Voices issued the following news release: * * * Senate-passed permitting deal benefits corporate polluters at great cost to our communities November 20, 2026 WASHINGTON, D.C. -- Last night, the Senate passed the Bipartisan American Affordability and Jobs Act -- a permitting deal that attempts to eliminate some of our most important community and environmental protections in an effort to speed up the permitting of infrastructure projects. Despite some changes to the bill made through the manager's amendment, the version ofthe bill that passed the Senate still contains provisions that put Appalachian communities and our natural heritage at risk.
The effects of climate change are being felt throughout Appalachia in the form of more frequent and devastating flooding, fires and droughts. We support efforts to build more renewable energy to meet our growing energy needs, while reducing our climate impacts. But this bill would speed up the construction of fossil-fuel infrastructure, data centers and other harmful facilities at the cost of eliminating protections for clean water, endangered species and community engagement. In addition, the promise of new renewable energy projects hinges on whether the Trump-Vance administration stops stymying these projects -- something already contradicted by the president's recent statements and the administration's actions.
Appalachian communities have long borne a disproportionate burden of fossil-fuel infrastructure, and this bill would only make it easier to build data centers, power plants and methane gas pipelines in our communities, and make it harder for local people to have a say. As a result, families would be exposed to more air and water pollution, suffer increased health problems and face higher healthcare and water treatment costs.
The health and safety of our communities is not a bargaining chip to be traded. Our communities deserve better. We urge members of the House to oppose this harmful legislation and work together in a more open and transparent process to improve permitting processes and address climate change without sacrificing our environmental and community protections.
Statement from Executive Director Tom Cormons:
"We are disappointed that the Senate has voted to advance this major environmental rollback in spite of the significant harm it would bring to our communities. We all deserve a safe and healthy environment, and a say in whether infrastructure projects like data centers and methane gas pipelines are built in our backyard. We appeal to members of the House to oppose this dangerous bill."
* * *
Original text here: https://appvoices.org/2026/11/20/baaja-senate-passage/
* * *
Senate-passed permitting deal benefits corporate polluters at great cost to our communities
November 20, 2026
WASHINGTON, D.C. -- Last night, the Senate passed the Bipartisan American Affordability and Jobs Act -- a permitting deal that attempts to eliminate some of our most important community and environmental protections in an effort to speed up the permitting of infrastructure projects. Despite some changes to the bill made through the manager's amendment, the version of ... Show Full Article BOONE, North Carolina, Nov. 21 [Category: Sociological] -- Appalachian Voices issued the following news release: * * * Senate-passed permitting deal benefits corporate polluters at great cost to our communities November 20, 2026 WASHINGTON, D.C. -- Last night, the Senate passed the Bipartisan American Affordability and Jobs Act -- a permitting deal that attempts to eliminate some of our most important community and environmental protections in an effort to speed up the permitting of infrastructure projects. Despite some changes to the bill made through the manager's amendment, the version ofthe bill that passed the Senate still contains provisions that put Appalachian communities and our natural heritage at risk.
The effects of climate change are being felt throughout Appalachia in the form of more frequent and devastating flooding, fires and droughts. We support efforts to build more renewable energy to meet our growing energy needs, while reducing our climate impacts. But this bill would speed up the construction of fossil-fuel infrastructure, data centers and other harmful facilities at the cost of eliminating protections for clean water, endangered species and community engagement. In addition, the promise of new renewable energy projects hinges on whether the Trump-Vance administration stops stymying these projects -- something already contradicted by the president's recent statements and the administration's actions.
Appalachian communities have long borne a disproportionate burden of fossil-fuel infrastructure, and this bill would only make it easier to build data centers, power plants and methane gas pipelines in our communities, and make it harder for local people to have a say. As a result, families would be exposed to more air and water pollution, suffer increased health problems and face higher healthcare and water treatment costs.
The health and safety of our communities is not a bargaining chip to be traded. Our communities deserve better. We urge members of the House to oppose this harmful legislation and work together in a more open and transparent process to improve permitting processes and address climate change without sacrificing our environmental and community protections.
Statement from Executive Director Tom Cormons:
"We are disappointed that the Senate has voted to advance this major environmental rollback in spite of the significant harm it would bring to our communities. We all deserve a safe and healthy environment, and a say in whether infrastructure projects like data centers and methane gas pipelines are built in our backyard. We appeal to members of the House to oppose this dangerous bill."
* * *
Original text here: https://appvoices.org/2026/11/20/baaja-senate-passage/
Americas Society/Council of the Americas: Honoring Rappi, Banco Do Brasil, and Leaders From Atlas Renewable Energy, LATAM Airlines
NEW YORK, Nov. 21 -- The Americas Society/Council of the Americas issued the following news release:
* * *
Honoring Rappi, Banco do Brasil, and Leaders from Atlas Renewable Energy, LATAM Airlines
COA's BRAVO Business Awards recognized these firms and executives for having the vision to drive innovation and economic development across Latin America.
-
Miami, November 20, 2026--Council of the Americas (COA) held the 31st BRAVO Business Awards on November 19 at the Loews Coral Gables Hotel in Miami, honoring leaders and companies whose vision and achievements have driven innovation, expanded ... Show Full Article NEW YORK, Nov. 21 -- The Americas Society/Council of the Americas issued the following news release: * * * Honoring Rappi, Banco do Brasil, and Leaders from Atlas Renewable Energy, LATAM Airlines COA's BRAVO Business Awards recognized these firms and executives for having the vision to drive innovation and economic development across Latin America. - Miami, November 20, 2026--Council of the Americas (COA) held the 31st BRAVO Business Awards on November 19 at the Loews Coral Gables Hotel in Miami, honoring leaders and companies whose vision and achievements have driven innovation, expandedopportunities, and increased investment across the Americas.
"Latin America is not simply a market for global innovation. It is a source of it. Tonight, that tradition continues," said Maria Lourdes Teran, vice president of AS/COA Miami and chair of the BRAVO Business Awards. "Tonight's honorees represent very different chapters in that transformation, from a financial institution founded more than two centuries ago to companies reshaping how we generate energy, participate in the digital economy, and connect across borders. Their stories reflect the extraordinary ambition and ingenuity of Latin America's business community."
Roberto Alvo, CEO of LATAM Airlines, received the BRAVO CEO of the Year Award for his outstanding leadership in transforming LATAM Airlines during one of the most challenging periods in the aviation industry's history, leading the company through changes that strengthened its financial performance, accelerated its digital evolution and positioned it for long-term growth.
"I am deeply honored to receive the 2026 BRAVO CEO of the Year Award. This recognition reflects the commitment and resilience of the more than 44,000 people who make up LATAM Airlines Group across the region," said Alvo. "When I became CEO in March 2020, our industry was facing one of its most challenging moments. Together, we navigated a profound financial restructuring and laid the foundations for a stronger, more resilient company. Today, LATAM is achieving its strongest financial performance to date, while advancing its digital transformation and operational efficiency. I share this recognition with everyone who has been part of this journey and continues to help shape LATAM's future."
Banco do Brasil was honored with the BRAVO Legacy Award, accepted by Francisco Lassalvia, its executive vice president and chief wholesale officer. As Brazil's oldest financial institution and one of Latin America's largest banks, Banco do Brasil was recognized for its longstanding contributions to Brazil's economic, social, and sustainable development.
"For more than two centuries, Banco do Brasil has helped shape the future of Brazilians, both at home and around the world. Trust remains our greatest asset, built on consistency, transparency, and respect," said Lassalvia. "Since 2023, we have invested 26.2 billion reals in technology, empowering our people to embrace AI, and deliver more personalized, human-centered experiences. This is our Phygital strategy in action: combining the strength of our physical presence with the power of digital innovation. Receiving the BRAVO Legacy Award is a tremendous honor and a reaffirmation of our commitment to bringing together the strength of our legacy and the innovation needed to remain close and relevant to the people we serve."
Rappi received the BRAVO Beacon of Innovation Award, accepted by one of its founders, Felipe Villamarin. The company helped pioneer the super app model in Latin America, reshaping how millions access goods and services while giving businesses new ways to grow.
"Since we founded the company, one of our most important missions has been to help people in Latin America believe and truly feel that world-class technology companies can be built in the region," said Villamarin. "And this award validates that innovation, perseverance, and the realization that, despite the many obstacles involved in building a company in Latin America, anything is possible."
Carlos Barrera, founder and CEO of Atlas Renewable Energy, was honored with the BRAVO Innovative CEO of the Year Award for his ability to turn the company he started in 2017 into the largest independent renewable energy producer in Latin America, helping accelerate the region's transition to a more sustainable future.
"It is an honor to be recognized as BRAVO Innovative CEO of the Year. At Atlas, innovation starts with a team willing to challenge how things are done. That culture has built the clean energy infrastructure powering many of Latin America's leading companies. Our next interesting frontier is AI and data centers," said Barrera. "Latin America offers the two things the data center economy needs most: clean power at scale and speed to power. At Atlas, we intend to help the region seize the moment and continue partnering with large clients needing reliable power they can depend on. Thank you to the Council of the Americas for the important work you do in bridging the public and private sectors."
Earlier in the day, over 500 company founders, industry pioneers, government officials, and regional leaders gathered at the COA Symposium to explore the theme, "Latin America's Next Chapter: Growth, Investment & the AI Economy."
The symposium explored key themes shaping Latin America's future, including banking innovation, the expansion of Latin American companies in the United States, leadership during crises, and regional security risks.
AI was a central focus of the Symposium. Susan Segal, AS/COA's president and CEO, said that Latin America can be a builder in the AI economy, not only a user.
"With some of the cleanest energy matrices in the world, the region is well positioned to host the data centers and power that AI requires," said Segal. "Companies here are already moving from pilots to putting AI to work across their operations."
As Latin America looks to translate growing AI adoption into economic opportunities, two panels examined the infrastructure needed to power the AI economy and how businesses can use the technology to gain a competitive advantage.
The panel "Powering the AI Economy: Latin America's Data Center Potential" explored the region's potential to attract investment in data centers. Moderator Candela Macchi, head of Latin America Ratings & Research at Moody's Ratings, highlighted the region's advantages, including its renewable energy resources, while noting some of its challenges.
Ximena Rincon, minister of Energy of Chile, outlined three priorities the government is working on: providing certainty for investors, accelerating permits, and ensuring that the data processed also benefits the country.
Regarding the potential of the entire region, Rincon said: "Latin America can take advantage of its wealth in renewable energy generation, gas, and diesel, transforming this territory into an opportunity for the world, but also for its own inhabitants."
Following this conversation, a panel moderated by Alejandro Anderlic, director of Government and External Affairs for Latin America at Salesforce, focused on how the companies in the region can translate AI strategies into business value and competitive advantage.
"I think that this is the real first time in history where a continent like Latin America can actually leapfrog through technology," said Paula Bellizia, vice president for Latin America at Amazon Web Services. "Productivity is such an important outcome we want from our countries, and AI can be, if used right, can be what helps us to do that."
Adam Kaufman, head of Industry Transformation at Anthropic, noted that Latin America is one of the fastest-growing regions for AI adoption and encouraged leaders to be early adopters, adding that that their example can influence how the technology is used across their organizations.
In a panel moderated by Mauricio Janauskas, managing partner for Spanish Latin America at McKinsey & Company, participants discussed how the region can overcome challenges and seize opportunities in a changing global economy.
Carlos Capistran, head of Latin America and Canada Economics at Bank of America highlighted the importance of focusing on productivity.
"We need to make productivity a cornerstone of the agenda. We have to be dealing with productivity as if it were a crisis and we need to be delivering on that," said Capistran. "That I think needs to be the question to be asked and this is what we need to be thinking about in the region."
Andres Gluski, CEO of The AES Corporation, talked about the region's renewable energy potential and the need for consistent regulations.
"In the energy sector in itself, the issue is having consistent policies over time that allows investors to make low-risk returns that make it adequate to invest," he said.
The event also featured a conversation with Roberto Alvo, CEO of LATAM Airlines, moderated by Gabriela Frias, business anchor at CNN en Espanol. Alvo reflected on leading the company through the pandemic and its restructuring, emphasizing the importance of honest communication during a crisis.
A panel titled "Latin American Companies in the U.S. Market: Growth & Expansion," moderated by Julio Figueroa, CEO of Latin America at Citi, examined how Latin American companies have expanded across borders.
Roberto Lara, CEO of Castillo Hermanos emphasized that it's human-centered culture has helped the company to navigate challenges and expand into new markets. "This human-centric aspect is what has brought the company to where it is today [...] and it is what will keep Castillo Hermanos growing in the future and especially in the U.S. now," he said.
The Symposium also featured a leadership conversation with the 2026 BRAVO Business Awards honorees, moderated by Segal.
It continued with off-the-record sessions on security risks in the Americas, the digital transformation of Latin American consumers, and rebuilding Venezuela.
The conversation on Venezuela, moderated by Guillermo Zubillaga, head of the Venezuela Working Group at AS/COA, featured Xavier Prieto, country representative for Venezuela at CAF, among other participants, and focused on the investment and institutional conditions needed to rebuild the country.
The session on security risks featured Matias O'Farrell, vice president of corporate affairs for Latin America and Canada at Philip Morris International, alongside other panelists.
Juan Ignacio De Lorenzo, senior vice president and head of distribution for consumer lines at Chubb Latin America, and Adolfo Corujo, partner and managing director of strategy and AI at LLYC, joined the discussion on the digital transformation of the Latin American consumer. The session was moderated by Francisco Aldaya, panregional bureau chief at Bloomberg Linea.
* * *
Sponsors: Amazon, CAF-Development Bank of Latin America and the Caribbean, Chubb Latin America, LLYC, Philip Morris International, Bank of America, Castillo Hermanos, Citi, Moody's, Salesforce, The AES Corporation, BlackRock, FedEx, Grupo Mariposa, SBA Communications, Tower Strategy.
Knowledge Partner: McKinsey & Company.
Media Partners: Americas Quarterly, Bloomberg Linea, CNN en Espanol, El Pais, Exame.
* * *
Original text here: https://www.as-coa.org/articles/honoring-rappi-banco-do-brasil-and-leaders-atlas-renewable-energy-latam-airlines
[Category: Sociological]
* * *
Honoring Rappi, Banco do Brasil, and Leaders from Atlas Renewable Energy, LATAM Airlines
COA's BRAVO Business Awards recognized these firms and executives for having the vision to drive innovation and economic development across Latin America.
-
Miami, November 20, 2026--Council of the Americas (COA) held the 31st BRAVO Business Awards on November 19 at the Loews Coral Gables Hotel in Miami, honoring leaders and companies whose vision and achievements have driven innovation, expanded ... Show Full Article NEW YORK, Nov. 21 -- The Americas Society/Council of the Americas issued the following news release: * * * Honoring Rappi, Banco do Brasil, and Leaders from Atlas Renewable Energy, LATAM Airlines COA's BRAVO Business Awards recognized these firms and executives for having the vision to drive innovation and economic development across Latin America. - Miami, November 20, 2026--Council of the Americas (COA) held the 31st BRAVO Business Awards on November 19 at the Loews Coral Gables Hotel in Miami, honoring leaders and companies whose vision and achievements have driven innovation, expandedopportunities, and increased investment across the Americas.
"Latin America is not simply a market for global innovation. It is a source of it. Tonight, that tradition continues," said Maria Lourdes Teran, vice president of AS/COA Miami and chair of the BRAVO Business Awards. "Tonight's honorees represent very different chapters in that transformation, from a financial institution founded more than two centuries ago to companies reshaping how we generate energy, participate in the digital economy, and connect across borders. Their stories reflect the extraordinary ambition and ingenuity of Latin America's business community."
Roberto Alvo, CEO of LATAM Airlines, received the BRAVO CEO of the Year Award for his outstanding leadership in transforming LATAM Airlines during one of the most challenging periods in the aviation industry's history, leading the company through changes that strengthened its financial performance, accelerated its digital evolution and positioned it for long-term growth.
"I am deeply honored to receive the 2026 BRAVO CEO of the Year Award. This recognition reflects the commitment and resilience of the more than 44,000 people who make up LATAM Airlines Group across the region," said Alvo. "When I became CEO in March 2020, our industry was facing one of its most challenging moments. Together, we navigated a profound financial restructuring and laid the foundations for a stronger, more resilient company. Today, LATAM is achieving its strongest financial performance to date, while advancing its digital transformation and operational efficiency. I share this recognition with everyone who has been part of this journey and continues to help shape LATAM's future."
Banco do Brasil was honored with the BRAVO Legacy Award, accepted by Francisco Lassalvia, its executive vice president and chief wholesale officer. As Brazil's oldest financial institution and one of Latin America's largest banks, Banco do Brasil was recognized for its longstanding contributions to Brazil's economic, social, and sustainable development.
"For more than two centuries, Banco do Brasil has helped shape the future of Brazilians, both at home and around the world. Trust remains our greatest asset, built on consistency, transparency, and respect," said Lassalvia. "Since 2023, we have invested 26.2 billion reals in technology, empowering our people to embrace AI, and deliver more personalized, human-centered experiences. This is our Phygital strategy in action: combining the strength of our physical presence with the power of digital innovation. Receiving the BRAVO Legacy Award is a tremendous honor and a reaffirmation of our commitment to bringing together the strength of our legacy and the innovation needed to remain close and relevant to the people we serve."
Rappi received the BRAVO Beacon of Innovation Award, accepted by one of its founders, Felipe Villamarin. The company helped pioneer the super app model in Latin America, reshaping how millions access goods and services while giving businesses new ways to grow.
"Since we founded the company, one of our most important missions has been to help people in Latin America believe and truly feel that world-class technology companies can be built in the region," said Villamarin. "And this award validates that innovation, perseverance, and the realization that, despite the many obstacles involved in building a company in Latin America, anything is possible."
Carlos Barrera, founder and CEO of Atlas Renewable Energy, was honored with the BRAVO Innovative CEO of the Year Award for his ability to turn the company he started in 2017 into the largest independent renewable energy producer in Latin America, helping accelerate the region's transition to a more sustainable future.
"It is an honor to be recognized as BRAVO Innovative CEO of the Year. At Atlas, innovation starts with a team willing to challenge how things are done. That culture has built the clean energy infrastructure powering many of Latin America's leading companies. Our next interesting frontier is AI and data centers," said Barrera. "Latin America offers the two things the data center economy needs most: clean power at scale and speed to power. At Atlas, we intend to help the region seize the moment and continue partnering with large clients needing reliable power they can depend on. Thank you to the Council of the Americas for the important work you do in bridging the public and private sectors."
Earlier in the day, over 500 company founders, industry pioneers, government officials, and regional leaders gathered at the COA Symposium to explore the theme, "Latin America's Next Chapter: Growth, Investment & the AI Economy."
The symposium explored key themes shaping Latin America's future, including banking innovation, the expansion of Latin American companies in the United States, leadership during crises, and regional security risks.
AI was a central focus of the Symposium. Susan Segal, AS/COA's president and CEO, said that Latin America can be a builder in the AI economy, not only a user.
"With some of the cleanest energy matrices in the world, the region is well positioned to host the data centers and power that AI requires," said Segal. "Companies here are already moving from pilots to putting AI to work across their operations."
As Latin America looks to translate growing AI adoption into economic opportunities, two panels examined the infrastructure needed to power the AI economy and how businesses can use the technology to gain a competitive advantage.
The panel "Powering the AI Economy: Latin America's Data Center Potential" explored the region's potential to attract investment in data centers. Moderator Candela Macchi, head of Latin America Ratings & Research at Moody's Ratings, highlighted the region's advantages, including its renewable energy resources, while noting some of its challenges.
Ximena Rincon, minister of Energy of Chile, outlined three priorities the government is working on: providing certainty for investors, accelerating permits, and ensuring that the data processed also benefits the country.
Regarding the potential of the entire region, Rincon said: "Latin America can take advantage of its wealth in renewable energy generation, gas, and diesel, transforming this territory into an opportunity for the world, but also for its own inhabitants."
Following this conversation, a panel moderated by Alejandro Anderlic, director of Government and External Affairs for Latin America at Salesforce, focused on how the companies in the region can translate AI strategies into business value and competitive advantage.
"I think that this is the real first time in history where a continent like Latin America can actually leapfrog through technology," said Paula Bellizia, vice president for Latin America at Amazon Web Services. "Productivity is such an important outcome we want from our countries, and AI can be, if used right, can be what helps us to do that."
Adam Kaufman, head of Industry Transformation at Anthropic, noted that Latin America is one of the fastest-growing regions for AI adoption and encouraged leaders to be early adopters, adding that that their example can influence how the technology is used across their organizations.
In a panel moderated by Mauricio Janauskas, managing partner for Spanish Latin America at McKinsey & Company, participants discussed how the region can overcome challenges and seize opportunities in a changing global economy.
Carlos Capistran, head of Latin America and Canada Economics at Bank of America highlighted the importance of focusing on productivity.
"We need to make productivity a cornerstone of the agenda. We have to be dealing with productivity as if it were a crisis and we need to be delivering on that," said Capistran. "That I think needs to be the question to be asked and this is what we need to be thinking about in the region."
Andres Gluski, CEO of The AES Corporation, talked about the region's renewable energy potential and the need for consistent regulations.
"In the energy sector in itself, the issue is having consistent policies over time that allows investors to make low-risk returns that make it adequate to invest," he said.
The event also featured a conversation with Roberto Alvo, CEO of LATAM Airlines, moderated by Gabriela Frias, business anchor at CNN en Espanol. Alvo reflected on leading the company through the pandemic and its restructuring, emphasizing the importance of honest communication during a crisis.
A panel titled "Latin American Companies in the U.S. Market: Growth & Expansion," moderated by Julio Figueroa, CEO of Latin America at Citi, examined how Latin American companies have expanded across borders.
Roberto Lara, CEO of Castillo Hermanos emphasized that it's human-centered culture has helped the company to navigate challenges and expand into new markets. "This human-centric aspect is what has brought the company to where it is today [...] and it is what will keep Castillo Hermanos growing in the future and especially in the U.S. now," he said.
The Symposium also featured a leadership conversation with the 2026 BRAVO Business Awards honorees, moderated by Segal.
It continued with off-the-record sessions on security risks in the Americas, the digital transformation of Latin American consumers, and rebuilding Venezuela.
The conversation on Venezuela, moderated by Guillermo Zubillaga, head of the Venezuela Working Group at AS/COA, featured Xavier Prieto, country representative for Venezuela at CAF, among other participants, and focused on the investment and institutional conditions needed to rebuild the country.
The session on security risks featured Matias O'Farrell, vice president of corporate affairs for Latin America and Canada at Philip Morris International, alongside other panelists.
Juan Ignacio De Lorenzo, senior vice president and head of distribution for consumer lines at Chubb Latin America, and Adolfo Corujo, partner and managing director of strategy and AI at LLYC, joined the discussion on the digital transformation of the Latin American consumer. The session was moderated by Francisco Aldaya, panregional bureau chief at Bloomberg Linea.
* * *
Sponsors: Amazon, CAF-Development Bank of Latin America and the Caribbean, Chubb Latin America, LLYC, Philip Morris International, Bank of America, Castillo Hermanos, Citi, Moody's, Salesforce, The AES Corporation, BlackRock, FedEx, Grupo Mariposa, SBA Communications, Tower Strategy.
Knowledge Partner: McKinsey & Company.
Media Partners: Americas Quarterly, Bloomberg Linea, CNN en Espanol, El Pais, Exame.
* * *
Original text here: https://www.as-coa.org/articles/honoring-rappi-banco-do-brasil-and-leaders-atlas-renewable-energy-latam-airlines
[Category: Sociological]
